Wang Lingke sold $3.8M of LIFE

Wang Lingke (President) sold 118,333 shares of Ethos Technologies Inc. (LIFE) at an average of $32.19 ($32.11–$32.62, $3.81M total) across 2 trades on 2026-11-19 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang Lingke
Published Nov 21, 2026, 12:24 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 21, 2026, 12:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LIFE
Neutral
medium confidence
Mentioned
$LIFE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFENeutralLow
01

Why it matters

The disclosed sale value is about $3.81M across two trades at roughly $32.11 to $32.62, with holdings after the transaction of 1,479,800 shares.

02

Market read

This is a routine insider-sale disclosure with limited actionable signal due to the stated 10b5-1 plan.

03

What to watch

Traders may focus more on whether additional insider transactions cluster around the same window, rather than one isolated sale.

Relevance 5/10Novelty 5/10Timing: filing reported after the 2026-11-19 sale trades

Background

The article is a primary-source SEC Form 4 insider transaction for Ethos Technologies Inc. (LIFE), reporting an open-market sale by President Wang Lingke.

Company-level read

Ticker impact

$LIFENeutralMedium confidence
Context

Ethos Technologies insider Wang Lingke sold about 118,333 shares in open-market trades under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact as the sale is pre-arranged under Rule 10b5-1, though it may add slight selling-overhang optics.

Evidence & confidence

Insider sales can be interpreted as diversification, but the filing explicitly notes a pre-arranged 10b5-1 plan, reducing the signal strength versus discretionary selling.

Market effects

No clear sector read-through from a single insider sale disclosure.

None.

None.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, the market may treat it as routine diversification with minimal price consequence.

Key entities

  • LIFE

    Ethos Technologies Inc., the issuer of the Form 4 insider sale.

  • Wang Lingke

    President of Ethos Technologies Inc., reported open-market sale under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LIFEHighAI 8/10

Why is Ethos Technologies stock surging today?

Ethos Technologies (LIFE) stock rose 11.4% premarket after Q3 revenue of $235M beat estimates and guidance. Adjusted EBITDA was $35M, also topping forecasts. New policies increased 189% YoY. Citizens raised its price target to $55. Full-year 2026 revenue guidance increased to $838M-$842M.

$LIFEMed

Ethos Technologies Inc (LIFE) (Q3 2026) Earnings Call Highlights: Triple-Digit Revenue

Ethos Technologies (LIFE) reported Q3 2026 revenue of $235M, up 151% YoY, with adjusted EBITDA of $35M, exceeding guidance. Direct and third-party channel revenues grew 112% and 209% YoY, respectively. Contribution margin declined to 28%, and Q4 guidance implies growth deceleration to 102% YoY. Management discussed channel growth, carrier relationships, and margin dynamics during the earnings call.

$LIFEHigh

Ethos Reports Third Quarter Fiscal Year 2026 Financial Results

Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ethos Reports Third Quarter Fiscal Year 2026 Financial Results • Q3 Revenue grew 151% year-over-year to $235 million • Q3 Direct Channel Revenue grew 112% year-over-year to $119 million • Q3 Third-Party Channel Revenue grew 209% year-over-year to $116 million Austin,